AGA
Altrinsic Global Advisors’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-27,000
| Closed | -$1.58M | – | 59 |
|
2021
Q4 | $1.58M | Hold |
27,000
| – | – | 0.05% | 62 |
|
2021
Q3 | $1.6M | Sell |
27,000
-3,000
| -10% | -$178K | 0.05% | 67 |
|
2021
Q2 | $2.6M | Hold |
30,000
| – | – | 0.08% | 59 |
|
2021
Q1 | $2.47M | Sell |
30,000
-10,000
| -25% | -$825K | 0.08% | 60 |
|
2020
Q4 | $3.64M | Sell |
40,000
-20,000
| -33% | -$1.82M | 0.12% | 48 |
|
2020
Q3 | $2.4M | Hold |
60,000
| – | – | 0.1% | 53 |
|
2020
Q2 | $2.06M | Hold |
60,000
| – | – | 0.09% | 55 |
|
2020
Q1 | $1.33M | Sell |
60,000
-10,000
| -14% | -$222K | 0.07% | 60 |
|
2019
Q4 | $1.37M | Hold |
70,000
| – | – | 0.06% | 61 |
|
2019
Q3 | $1.09M | Hold |
70,000
| – | – | 0.05% | 68 |
|
2019
Q2 | $1.42M | Hold |
70,000
| – | – | 0.07% | 66 |
|
2019
Q1 | $1.23M | Hold |
70,000
| – | – | 0.06% | 72 |
|
2018
Q4 | $898K | Hold |
70,000
| – | – | 0.04% | 68 |
|
2018
Q3 | $1.14M | Buy |
70,000
+20,000
| +40% | +$326K | 0.05% | 72 |
|
2018
Q2 | $567K | Buy |
+50,000
| New | +$567K | 0.02% | 79 |
|